Skip to content
20-F

Annual Report (Foreign)

Amryt Pharma plc

0001140361-22-016877

← back to feed
Filed
Apr 29, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2021 · Dec 31, 2021 235.85M sh
Shares Diluted FY 2021 · Dec 31, 2020 158.59M sh
Shares Diluted FY 2021 · Dec 31, 2019 75.87M sh
Shares Outstanding FY 2021 · Dec 31, 2021 319.81M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 $15.54M
Operating Cash Flow FY 2021 · Dec 31, 2020 $26.89M
Operating Cash Flow FY 2021 · Dec 31, 2019 −$37.47M
Cash And Equivalents FY 2021 · Dec 31, 2021 $113.03M
Cash And Equivalents FY 2021 · Dec 31, 2020 $118.8M
Cash And Equivalents FY 2021 · Dec 31, 2019 $67.23M
Cash And Equivalents FY 2021 · Dec 31, 2018 $11.23M
Stockholders Equity FY 2021 · Dec 31, 2021 $356.66M
Stockholders Equity FY 2021 · Dec 31, 2020 $66.14M
Stockholders Equity FY 2021 · Dec 31, 2019 $131.83M
Stockholders Equity FY 2021 · Dec 31, 2018 −$3.7M
Current Liabilities FY 2021 · Dec 31, 2021 $157.28M
Current Liabilities FY 2021 · Dec 31, 2020 $101.18M
Total Liabilities FY 2021 · Dec 31, 2021 $459.4M
Total Liabilities FY 2021 · Dec 31, 2020 $470.45M
Current Assets FY 2021 · Dec 31, 2021 $282.71M
Current Assets FY 2021 · Dec 31, 2020 $202.98M
Total Assets FY 2021 · Dec 31, 2021 $816.06M
Total Assets FY 2021 · Dec 31, 2020 $536.59M
Eps Diluted FY 2021 · Dec 31, 2021 $0.00
Eps Diluted FY 2021 · Dec 31, 2020 −$0.66
Eps Diluted FY 2021 · Dec 31, 2019 −$0.83
Eps Basic FY 2021 · Dec 31, 2021 $0.00
Eps Basic FY 2021 · Dec 31, 2020 −$0.66
Eps Basic FY 2021 · Dec 31, 2019 −$0.83
Sga Expense FY 2021 · Dec 31, 2021 $92M
Sga Expense FY 2021 · Dec 31, 2020 $76.67M
Sga Expense FY 2021 · Dec 31, 2019 $35.5M
Rd Expense FY 2021 · Dec 31, 2021 $37.73M
Rd Expense FY 2021 · Dec 31, 2020 $27.62M
Rd Expense FY 2021 · Dec 31, 2019 $15.83M
Net Income FY 2021 · Dec 31, 2021 $1M
Net Income FY 2021 · Dec 31, 2020 −$104.53M
Net Income FY 2021 · Dec 31, 2019 −$63M
Operating Income FY 2021 · Dec 31, 2021 −$38.59M
Operating Income FY 2021 · Dec 31, 2020 −$46.46M
Operating Income FY 2021 · Dec 31, 2019 −$50.48M
Gross Profit FY 2021 · Dec 31, 2021 $116.42M
Gross Profit FY 2021 · Dec 31, 2020 $63.58M
Gross Profit FY 2021 · Dec 31, 2019 $19.39M
Cost Of Revenue FY 2021 · Dec 31, 2021 $106.12M
Cost Of Revenue FY 2021 · Dec 31, 2020 $119.03M
Cost Of Revenue FY 2021 · Dec 31, 2019 $38.73M
Revenue FY 2021 · Dec 31, 2021 $222.54M
Revenue FY 2021 · Dec 31, 2020 $182.61M
Revenue FY 2021 · Dec 31, 2019 $58.12M